Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioLineRx (BLRX) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for BioLineRx (BLRX) over the last 1 years, with Jun 2025 value amounting to 0.40.

  • BioLineRx's Asset Utilization Ratio rose 90.07% to 0.40 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.40, marking a year-over-year increase of 90.07%. This contributed to the annual value of 0.56 for FY2024, which is N/A change from last year.
  • BioLineRx's Asset Utilization Ratio amounted to 0.40 in Q2 2025, which was down 26.66% from 0.54 recorded in Q1 2025.
  • In the past 5 years, BioLineRx's Asset Utilization Ratio registered a high of 0.63 during Q4 2024, and its lowest value of 0.04 during Q4 2023.
  • In the last 3 years, BioLineRx's Asset Utilization Ratio had a median value of 0.28 in 2024 and averaged 0.32.
  • Data for BioLineRx's Asset Utilization Ratio shows a peak YoY surged of 1,600.14% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows BioLineRx's Asset Utilization Ratio stood at 0.04 in 2023, then skyrocketed by 1,600.14% to 0.63 in 2024, then surged by 90.07% to 0.40 in 2025.
  • Its Asset Utilization Ratio stands at 0.40 for Q2 2025, versus 0.54 for Q1 2025 and 0.63 for Q4 2024.